You are here

  • Home
  • Archive
  • Volume 81, Issue 10
  • Response to: ‘High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab’ by Conticini et al

Citation Tools

Article menu
Download PDFPDF
Correspondence response
Response to: ‘High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab’ by Conticini et al

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ramiro S, Mostard R, Landewé RB
Response to: ‘High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab’ by Conticini et al
Annals of the Rheumatic Diseases 2022;81:e203.